Skip to main content
OpenTrials
Completed

NCT Number: NCT02646306

A New Shoulder Proprioceptive Rehabilitative Tool (SRPT) for the Evaluation of the Role of the Shoulder During Reaching

The aim of the study focused on the creation of a rehabilitative measuring device (SRPT-shoulder proprioceptive rehabilitation tool) and the development of the examination methodology for assessing the proprioception of the glenohumeral joint respect to scapula abduction, within the movement of antepulsion on the sagittal plane both in healthy subjects and in patients with shoulder impingement syndrome.

Completed

Looking for future studies?

Notify Me

Key information

Age range

55 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Umberto I Hospital

Rome, 00165, Italy

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Right-handed
  • Diagnosis of subacromial right impingement syndrome performed by the orthopedic specialist (nuclear magnetic resonance and/or ultrasound examination)
  • Neer stages 1, 2 and 3
  • Presence of pain 3 <VAS<8 at baseline
  • Age between 55 and 65 years.

Exclusion criteria

  • Diabetes mellitus
  • Inflammatory systemic diseases
  • CNS and/or PNS diseases
  • Systemic infectious diseases
  • Neoplastic diseases
  • Assumption of antidepressants and/or anxiolytics and/or other medications that can affect attention and sensory
  • Visual problems not properly compensated
  • Previous surgery to the shoulder

Treatment and study plan

shoulder proprioceptive rehabilitation tool

Other

Using of this tool to measure which is the average error in reaching back in both healthy subjects and subjects with shoulder impingement syndrome starting from the assumption that the shoulder, through the articulation scapulothoracic, helps to determine direction and distance during the "reaching" of an object.

Other names: SRPT

Primary outcomes

  1. Evaluation of the Visual Analogue Scale (VAS) at baseline

    Time frame: baseline

    It is an instrument that enables patients to express their pain intensity as a numerical value. Patients were asked to mark the point that corresponded to their perceived pain intensity on a 10-cm line, with 0 indicating the absence of pain and 10 reflecting the most severe pain

Secondary outcomes

  1. Evaluation of the short form of the Disabilities of the Arm, Shoulder and Hand questionnaire (Quick-DASH) at baseline

    Time frame: baseline

    The short form (11 item) of the Disabilities of the Arm, Shoulder and Hand questionnaire (Quick-DASH) measures physical ability and symptoms of the upper extremity and explores the impact of functional impairment and pain on daily-living tasks, as well as on social and recreational activities, work and sleep. The score ranges from 0 to 100 points, with 0 reflect- ing no disability and 100 corresponding to the most severe disability

  2. Evaluation of the Constant-Murley shoulder outcome score at baseline

    Time frame: baseline

    It is based on subjective (sleep, work, and recreational activities) and objective (ROM and strength) components, adjusted for age and sex, according to normative values reported by Yian et al. The score ranges from 0 (worst result) to 100 (best result).

Sponsors and collaborators

Lead sponsor

University of Roma La Sapienza

Other

Registry information

Official study title

A New Neurocognitive Interpretation of the Shoulder Position Sense During Reaching

Acronym: SRPT-Iphase

Important dates

Study start
2015
Primary completion
2015
Study completion
2016
First posted
Jan 5, 2016
Registry last updated
Mar 23, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.